Search results
Low stress resilience is linked to increased risk of psoriasis
Medical Xpress· 4 days agoAs part of the enlistment process, all the men underwent psychological assessment in accordance with...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 4 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
‘Horrific’ potential early warning sign for autoimmune disease revealed in new study
NY Post via Yahoo News· 3 days agoTwenty-four million to 50 million Americans have an autoimmune disease, which is when the body’s...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 4 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 5 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice...
Johnson & Johnson (NYSE:JNJ) Trading Down 1.1%
ETF DAILY NEWS· 9 hours agoShares of Johnson & Johnson (NYSE:JNJ – Get Free Report) were down 1.1% during mid-day trading on Thursday . The company traded as low as $151.70 and last traded at $151.81. Approximately 1,428,737 ...
Studies Show Linked Biological Pathways Driving Skin Inflammation
FOX 5 San Diego· 5 days agoA certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to ...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? | The Motley...
The Motley Fool· 5 days agoWall Street is feeling pretty good about AbbVie's (ABBV -1.19%) performance in 2024 so far. Chen...
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 1 day agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 5 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...